Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8745985 | 0.73 | — | — | |
| SCHEMBL13412034 | 0.73 | — | — | |
| SCHEMBL880842 | 0.71 | AHCY (0.36) | AKR1B1AHCY | |
| SCHEMBL20256972 | 0.71 | AKR1B1 (0.35) | AKR1B1AHCY | |
| SCHEMBL17589372 | 0.71 | AKR1B1 (0.35) | AKR1B1AHCY | |
| SCHEMBL14389187 | 0.70 | AKR1B1 (0.39) | AKR1B1AHCY | |
| SCHEMBL17309109 | 0.70 | AKR1B1 (0.33) | AKR1B1AHCY | |
| SCHEMBL18532037 | 0.68 | AKR1B1 (0.37) | AKR1B1AHCY | |
| SCHEMBL3503633 | 0.67 | — | — | |
| SCHEMBL9070722 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017213854-A1 | PHARMACEUTICAL COMPOSITION COMPRISING ETEPLIRSEN | SAREPTA THERAPEUTICS, INC. (US) | 2017-12-14 | — | — | WO | disclosed |
| WO-2017205879-A2 | PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS | SAREPTA THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | WO | disclosed |
| WO-2017205880-A1 | PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS | SAREPTA THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | WO | disclosed |
| WO-2017205513-A1 | PROCESSES FOR PREPARING PHOSPHORODIAMIDATE MORPHOLINO OLIGOMERS | SAREPTA THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | WO | disclosed |
| WO-2017205496-A1 | PROCESSES FOR PREPARING OLIGOMERS | SAREPTA THERAPEUTICS, INC. (US) | 2017-11-30 | — | — | WO | disclosed |